- Exchanges
- BSE, NSE
- Industry
- Healthcare Service Provider
- Issue
- Book building
Thyrocare Technologies IPO
₹618.80
+38.74% on listing
Listing-day close · NSE · 9 May 2016 · issue price ₹446
Thyrocare Technologies’ ₹479 crore IPO was priced at ₹446 a share. It listed on the NSE on 9 May 2016 and closed its first day at ₹618.80, up 38.74% on the issue price.
Timeline
- Opens
- Closes
- Allotment
- Listing
Issue details
- Issue size
- ₹479 Cr
- Fresh issue
- —
- Offer for sale
- ₹479 Cr
- Lot size
- 33 shares
- Minimum investment
- ₹14,718
- Face value
- ₹10
- Registrar
- MUFG Intime India
Subscription
| Category | Shares offered | Times subscribed |
|---|---|---|
| Total | — | 52.27× |
Overall, from the basis of allotment.
Financials and valuation
- Market cap (post-issue)
- ₹2,396 Cr
- Promoter holding
- 64.96% → 63.96%
From the offer documents.
Listing
- Listing date
- 9 May 2016
- Issue price
- ₹446
- Open
- ₹665.00
- High
- ₹665.00
- Low
- ₹605.80
- Close
- ₹618.80
Listing day on the NSE. The close was +38.74% on the issue price.
THYROCARE share price todayFAQs
When did the Thyrocare Technologies IPO open and close?
It opened on 27 Apr 2016 and closed on 29 Apr 2016.
What was the Thyrocare Technologies IPO price?
The price band was ₹420–446 a share. The final issue price was ₹446.
What is the lot size and minimum investment?
One lot is 33 shares, ₹14,718 at ₹446 a share. Retail investors apply in whole lots.
How much did Thyrocare Technologies raise?
₹479 crore: ₹479 crore offered by existing shareholders.
How many times was the Thyrocare Technologies IPO subscribed?
52.27 times overall.
How did Thyrocare Technologies list?
It listed on the NSE on 9 May 2016 at ₹665.00 and closed the day at ₹618.80, up 38.74% on the ₹446 issue price.
Who is the registrar of the Thyrocare Technologies IPO?
MUFG Intime India handles the allotment, refunds and credit of shares.
For information only. Not investment advice or a research report.
Full disclaimerSee how an IPO fits your plan
Armor checks every holding against your goals, risk and timeline.
Get the app